Medical Microbiology
AMR remains a crucial concern in the field of medical microbiology. Researchers are dedicated to comprehending the underlying mechanisms of resistance, developing novel antimicrobial agents, and promoting responsible antimicrobial stewardship. To assess disease severity, prognosis, and treatment response in infectious diseases, researchers are focusing on identifying biomarkers and utilizing predictive models.
Immunotherapy, including monoclonal antibodies and convalescent plasma therapy, is being explored as a potential treatment for specific infectious diseases. Additionally, researchers are investigating the potential of microbiota transplantation, akin to fecal microbiota transplantation (FMT), as a therapy for various conditions related to dysbiosis and gastrointestinal health. Throughout the session, the importance of staying updated on the most recent innovations and research advances will be emphasized.